bpc 157 peptide human data safety Would you take a drug tested only in rats? The evidence in humans for the and efficacy of BPC-157 is EXTREMELY limited. People need to understand what we do and don't Body Protecting Compound 157 (BPC-157

The mechanisms involve upregulating survival genes, reducing inflammatory mediators, activating vascular bypass pathways, and maintaining blood flow despite vessel occlusion

Therapy with a GLP-1 RA or sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) that has proven CV benefit is recommended for initial therapy, with or without metformin based on glycemic needs, in patients with indicators of high-risk or established CV disease

Protects the Heart & Circulatory System May support cardiovascular health

What This Product Is NOT: NOT an FDA-Approved Drug: BPC-157 has not undergone the rigorous clinical trial process required for pharmaceutical approval

Don't be stingy here, the more you fill this layer, the richer and more professional the finished container will look